Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
HEXB Gene GM2-gangliosidosis type 2 NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
KCND3 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 777 | 770 |
|
Ataxia / Spastic Paraplegia Comprehensive Panel Centogene AG - the Rare Disease Company Germany | 451 | 452 |
|
Ataxia / Spastic Paraplegia Panel Centogene AG - the Rare Disease Company Germany | 442 | 443 |
|
Centogene AG - the Rare Disease Company Germany | 289 | 275 |
|
PreventionGenetics, part of Exact Sciences United States | 61 | 36 |
|
Genomic UnityⓇ Comprehensive Ataxia Analysis (includes STR analysis of 16 loci) Variantyx, Inc. United States | 52 | 53 |
|
Ambry Genetics United States | 91 | 42 |
|
Ambry Genetics United States | 236 | 167 |
|
Ambry Genetics United States | 189 | 92 |
|
Genetic Services Laboratory University of Chicago United States | 294 | 481 |
|
Inherited Cadiac Disorders Panel Dhiti Omics Technologies Private Ltd India | 60 | 33 |
|
Hereditary ataxias. NGS panel of 139 genes. Genologica Medica Spain | 220 | 139 |
|
Ataxia panel. NGS panel of 157 genes. Genologica Medica Spain | 247 | 156 |
|
CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 25 | 14 |
|
Arrhythmia & Cardiomyopathy Panel, Comprehensive CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 211 | 93 |
|
Arrhythmia Panel, Comprehensive CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 71 | 36 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.